CVE-2022-26419

Rockwell Automation Studio 5000 Logix Designer Code Injection

Description

Omron CX-Position (versions 2.5.3 and prior) is vulnerable to multiple stack-based buffer overflow conditions while parsing a specific project file, which may allow an attacker to locally execute arbitrary code.

Remediation

Solution:

  • Omron has provided Version 2.5.4, which is only available to paying users who use the “Auto Update” function. Please contact Omron technical Support or an Omron representative for specific update information.

Categories

7.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.64%
Third-Party Advisory cisa.gov Third-Party Advisory zerodayinitiative.com Third-Party Advisory zerodayinitiative.com Third-Party Advisory zerodayinitiative.com Third-Party Advisory zerodayinitiative.com
Affected: Omron CX-Position
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-26419?
CVE-2022-26419 has been scored as a high severity vulnerability.
How to fix CVE-2022-26419?
To fix CVE-2022-26419: Omron has provided Version 2.5.4, which is only available to paying users who use the “Auto Update” function. Please contact Omron technical Support or an Omron representative for specific update information.
Is CVE-2022-26419 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-26419 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-26419?
CVE-2022-26419 affects Omron CX-Position.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.